BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schierová D, Březina J, Mrázek J, Fliegerová KO, Kvasnová S, Bajer L, Drastich P. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells 2020;9:E2283. [PMID: 33066233 DOI: 10.3390/cells9102283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ponce-Alonso M, García-Hoz C, Halperin A, Nuño J, Nicolás P, Martínez-Pérez A, Ocaña J, García-Pérez JC, Guerrero A, López-Sanromán A, Cantón R, Roy G, Del Campo R. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis. Front Immunol 2021;12:683387. [PMID: 34149723 DOI: 10.3389/fimmu.2021.683387] [Reference Citation Analysis]
2 Eindor-Abarbanel A, Healey GR, Jacobson K. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Int J Mol Sci 2021;22:12506. [PMID: 34830388 DOI: 10.3390/ijms222212506] [Reference Citation Analysis]
3 Hu Y, Ye Z, Wu M, She Y, Li L, Xu Y, Qin K, Hu Z, Yang M, Lu F, Ye Q. The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Front Med (Lausanne) 2021;8:766126. [PMID: 34966755 DOI: 10.3389/fmed.2021.766126] [Reference Citation Analysis]
4 Březina J, Bajer L, Wohl P, Ďuricová D, Hrabák P, Novotný A, Koželuhová J, Lukáš M, Mrázek J, Fliegerová KO, Kvasnová S, Chahrazed M, Mareš J, Špičák J, Drastich P. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial. J Clin Med 2021;10:2753. [PMID: 34206663 DOI: 10.3390/jcm10132753] [Reference Citation Analysis]
5 Li C, Liu X, Tao G, Wang Y, Wu S, Suo J, Lv Y, Yu F, Suo X. A new landscape of rabbit gut microbiota shaped by the infection of precocious parasites of Eimeria intestinalis. Vet Parasitol 2021;300:109579. [PMID: 34784535 DOI: 10.1016/j.vetpar.2021.109579] [Reference Citation Analysis]
6 Huang C, Mei Q, Lou L, Huang Z, Fu Y, Fan J, Wang J, Yin N, Zheng Y, Lu Y, Zeng Y. Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance. Cells 2022;11:1851. [DOI: 10.3390/cells11111851] [Reference Citation Analysis]
7 Qu L, Lin X, Liu C, Ke C, Zhou Z, Xu K, Cao G, Liu Y. Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway. Front Pharmacol 2021;12:665376. [PMID: 34335244 DOI: 10.3389/fphar.2021.665376] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Adamkova P, Hradicka P, Kupcova Skalnikova H, Cizkova V, Vodicka P, Farkasova Iannaccone S, Kassayova M, Gancarcikova S, Demeckova V. Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease. Veterinary Sciences 2022;9:238. [DOI: 10.3390/vetsci9050238] [Reference Citation Analysis]
9 Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med 2021;10:959. [PMID: 33804464 DOI: 10.3390/jcm10050959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Karpinska-Leydier K, Amirthalingam J, Alshowaikh K, Iroshani Jayarathna A, Salibindla DBAMR, Paidi G, Ergin HE. Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Disease: A Systematic Review of the Literature. Cureus 2021;13:e16808. [PMID: 34350086 DOI: 10.7759/cureus.16808] [Reference Citation Analysis]
11 Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:748254. [PMID: 34819919 DOI: 10.3389/fendo.2021.748254] [Reference Citation Analysis]
12 Alkushi AG, Elazab ST, Abdelfattah-hassan A, Mahfouz H, Salem GA, Sheraiba NI, Mohamed EAA, Attia MS, El-shetry ES, Saleh AA, Elsawy NA, Ibrahim D. Multi-Strain-Probiotic-Loaded Nanoparticles Reduced Colon Inflammation and Orchestrated the Expressions of Tight Junction, NLRP3 Inflammasome and Caspase-1 Genes in DSS-Induced Colitis Model. Pharmaceutics 2022;14:1183. [DOI: 10.3390/pharmaceutics14061183] [Reference Citation Analysis]
13 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Reference Citation Analysis]
14 Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel) 2021;14:341. [PMID: 33917884 DOI: 10.3390/ph14040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]